%0 Journal Article
%T Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study
%A Huazheng Liang
%A Jiandao Yang
%A Lingda Shen
%A Shaoshi Wang
%A Yanyan Song
%J Archive of "Neuroscience Bulletin".
%D 2016
%R 10.1007/s12264-016-0020-2
%X Comparison of the modified Rankin score (mRS) among the three groups, 90 days after treatment. The percentage of patients with each mRS is color-coded and the percentage is shown in the color-coded bar. An mRS of 0¨C2 in the patients aged 60¨C80 was significantly more frequent than in both patient groups >80 years old, but an mRS of 0¨C2 in patients >80 years old who received rt-PA was not significantly more frequent than that of patients >80 years old who did not receive rt-PA treatment
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563742/